Patents
Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
10/2002
10/16/2002CN1374955A Oxa-and thiazole derivatives useful as antidiabetic and antibesity agents
10/16/2002CN1092657C One pot synthesis of 2-oxazolidinone derivatives
10/16/2002CN1092649C Thiazolidinone compounds or angina pectoris curing or preventing agent with the same as active ingredient
10/15/2002US6465661 Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors
10/15/2002US6465582 Polyoxazoline compounds and their use in surface coating compositions
10/15/2002US6465500 Indole derivatives as 5-HT1 agonists
10/15/2002US6465497 Arylthiazolidinedione derivatives
10/15/2002CA2253795C Substituted 4-arylbutyric acid derivatives as matrix metalloprotease inhibitors
10/10/2002WO2002079753A2 2-aminobenzoxazole derivatives and combinatorial libraries thereof
10/10/2002WO2002079200A1 3-heterocyclylpropanohydroxamic acid as procollagen c-proteinase inhibitors
10/10/2002WO2002079175A1 3-heterocyclylpropanohydroxamic acid pcp inhibitors
10/10/2002WO2002079174A2 Enantioselective synthesis of azetidinone intermediate compounds
10/10/2002WO2002079126A1 Cross-metathesis reaction of functionalized and substituted olefins using group 8 transition metal carbene complexes as metathesis catalysts
10/10/2002WO2002078626A2 Therapeutic combinations for cardiovascular and inflammatory indications
10/10/2002WO2002078625A2 Therapeutic combinations for cardiovascular and inflammatory indications
10/10/2002WO2002078448A1 Insecticide and method of controlling insects
10/10/2002WO2002057251A3 Process for preparing intermediates for the manufacture of discodermolide and discodermolide analogues
10/10/2002US20020147362 Synthesis of 2-Hydroxymethylglutamic acid and congeners thereof
10/10/2002CA2442481A1 3-heterocyclylpropanohydroxamic acid as procollagen c-proteinase inhibitors
10/10/2002CA2442368A1 Cross-metathesis reaction of functionalized and substituted olefins using group 8 transition metal carbene complexes as metathesis catalysts
10/10/2002CA2442328A1 Therapeutic combinations for cardiovascular and inflammatory indications
10/09/2002EP1246932A1 Conjugated fatty acids and related compounds, and method for their enzymatic preparation
10/09/2002EP1246795A2 Antibacterial agents
10/09/2002EP1246621A1 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
10/09/2002EP0958279A4 Catalyst compositions and processes for olefin polymers and copolymers
10/09/2002EP0939755B1 Oxazoline arthropodicides
10/08/2002USRE37873 Phenylacetic acid derivatives, preparation thereof and intermediates therefor, and compositions containing them
10/08/2002US6462198 Used in the control or prevention of acute and/or chronic neurological disorders such as restricted brain function caused by bypass operations or transplants, poor blood supply to the brain, spinal cord injuries, head injuries, hypoxia,
10/08/2002US6462092 Such as 3-((3-fluorophenyl)-((3-(trifluoromethyl)phenyl)-methyl)amino)-1,1,1 -trifluoro-2-propanol; cardiovascular disease, i.e. atherosclerosis and other coronary artery diseases
10/08/2002US6462073 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
10/08/2002US6462068 Heterocyclylmethyl-substituted pyrazole derivatives
10/08/2002US6462056 Oxazolidines as 5-HT2A-antagonists
10/03/2002WO2002076967A1 Process for making taxane derivatives
10/03/2002WO2002076960A1 Transition metal mediated process
10/03/2002WO2002076959A1 Five-membered heterocyclic alkanoic acid derivative
10/03/2002WO2002076958A1 Process for producing 5-substituted oxazole compounds and 5-substituted imidazole compounds
10/03/2002WO2002076957A1 Activator for peroxisome proliferator-activated receptor
10/03/2002WO2002076950A2 Imidiazole derivatives and their use as agonists selective at alpha 2b or 2b/2c adrenergic receptors
10/03/2002WO2002076939A2 Cysteine protease inhibitors
10/03/2002US20020143186 For prophylaxis and therapy of hyperglycemia, Type 1 diabetes, Type 2 diabetes, disorders of the lipid metabolism, such as dyslipidemia, and obesity
10/03/2002US20020143176 For therapy of diseases associdated with Factor VIIa and or inosine monophosphate dehydrogenase (IMPDH)
10/03/2002US20020143040 Having antipyretic action, analgesic action, anti-inflammatory action;side effect reduction
10/03/2002US20020142967 Thrombin inhibitors
10/02/2002EP1244642A1 Substituted oxazoles and thiazoles derivatives as hppar alpha activators
10/02/2002EP1244640A1 Oxazolidinone derivatives
10/02/2002CN1372557A Neurotrophin production/secretion promoting agent
10/02/2002CN1372543A new vitamin derivatives with cyclic substructures in the side chains, method and intermediates for their production and their use in the preparation of medicaments
10/01/2002US6458958 Process of preparing a piperidine derivative compound of the formula: acylating an .alpha.,.alpha.-disubstituted-methylbenzene derivative having the formula:
10/01/2002US6458852 Use of substituted N, N-bis-phenyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity
10/01/2002US6458849 Method of treating or preventing a ceip-mediated disorder in a subject by administering a therapeutically effective amount of a compound for strokes
10/01/2002US6458803 Substituted N-phenyl-N-heteroaralkyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity
10/01/2002US6458785 Aids therapy
10/01/2002US6458337 Diagnostic imaging contrast agent with improved in serum relaxivity
10/01/2002CA2210258C Substituted oxazolidine calpain and/or cathepsin b inhibitors
10/01/2002CA2203850C Novel n-phenyl-n-phenyliminonethylbenzamidines and their analogues as muscarinic receptor agonists
10/01/2002CA2009925C Method for enhancement of chemiluminescence
09/2002
09/27/2002CA2378876A1 Cyclohexylamine derivatives as subtype selective n-methyl-d-aspartate antagonists
09/26/2002WO2002074296A1 Remedies for solid cancer containing hydroxamic acid derivatives as the active ingredient
09/26/2002WO2002024636A3 N-acylsulfonamide apoptosis promoters
09/26/2002WO2001072695A1 Neovascularization inhibitors
09/26/2002WO2001052847A8 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging
09/26/2002US20020137978 Using as catalyst ruthenium or osmium carbene complexes containing an imidazolidine ligand
09/26/2002US20020137955 Reaction of an oxazole compound, (phenylisoserine derivative) with a hydroxyl-protected Baccatin III derivative to produce a taxane substrate that can be used to form paclitaxel and other taxanes
09/26/2002US20020137944 Methods for crystallization of n-(1(s)-ethoxycarbonyl-3-phenylpropyl)-l-alanine n-carboxyanhydride
09/26/2002US20020137782 Amide substituted benzimidazole or benzoxazole; regulating the interaction of vascular cell adhesion molecule-1 and fibronectin with the integrin vascular cell adhesion molecule very late antigen-4
09/26/2002US20020137781 Pesticides
09/26/2002US20020137778 Anticancer, antiarthritic, and antiinflammatory agents
09/26/2002US20020137754 Oxazolidinone thioamides with piperazine amide substituents
09/26/2002US20020137096 Solid phase synthesis; photolithography
09/26/2002US20020137068 Reagents for labeling biomolecules having aldehyde or ketone Moieties
09/26/2002CA2403903A1 Angiogenesis inhibitors
09/25/2002EP1243580A1 Heterocyclic imino compounds and fungicides and insecticides for agricultural and horticultural use
09/25/2002EP1242417A1 Oxazolidinones having a sulfoximine functionality and their use as antimicrobial agents
09/25/2002EP1242395A1 Benzoic acid esters of oxazolidinones having a hydroxyacetylpiperazine substituent
09/25/2002EP0980535B1 Photochromic compositions, photochromic compounds (co)polymer matrices
09/25/2002EP0968179B1 N-sulphonyl and n-sulphinyl amino acid amides as microbiocides
09/24/2002US6455566 Substituted 1-aryl-3-heteroaryl-thioureas (or isothioureas) as antiatherosclerotic agents
09/24/2002US6455529 Adhesion receptor antagonists
09/24/2002US6455519 Use of substituted N, N-disubstituted fused-heterocyclo amino compounds for inhibiting cholesteryl ester transfer protein activity
09/24/2002CA2246584C Method of treating tourette's syndrome
09/19/2002WO2002072542A2 Ph-dependent nmda receptor antagonists
09/19/2002WO2002053534A8 Vla-4 inhibitors
09/19/2002US20020132837 Process for preparing acetonides
09/19/2002US20020132807 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
09/19/2002CA2440284A1 Ph-dependent nmda receptor antagonists
09/18/2002EP1240165A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases
09/18/2002EP1240153A1 Aminothiazole inhibitors of cyclin dependent kinases
09/18/2002EP1240152A1 Ox(adi)azolyl-hydroxamic acids useful as procollagen c-proteinase inhibitors
09/18/2002EP1239877A2 MODULATORS OF CYTOKINE MEDIATED SIGNALLING PATHWAYS AND INTEGRIN $g(a) V?$g(b) 3? RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY
09/18/2002EP0950056B1 N-(pyridinylamino)isoindolines and related compounds
09/18/2002EP0865424B1 Pesticides
09/18/2002EP0842161B1 4,5-diaryl oxazole derivatives
09/18/2002CN1369489A Process for reaction of CO2 on heterocyclic compound under co-catalysis of transistion metal complex and organic alkali
09/18/2002CN1369488A Process for synthesizing annular carbonate or oxazolidinone compounds
09/17/2002US6452011 Process for production of piperidine derivatives
09/17/2002US6451988 An azo compound and a metal complex which are synthesized with the naphthol derivative
09/17/2002US6451842 Cyclic amine derivatives and their use as drugs
09/17/2002US6451830 Use of substituted N,N-disubstituted non-fused heterocyclo amino compounds for inhibiting cholesteryl ester transfer protein activity
09/17/2002US6451827 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia
09/17/2002US6451824 Sulfonylaminocarboxylic acids